These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 25832)

  • 41. The cardiovascular and autonomic effects of repeated administration of delta-9-tetrahydrocannabinol to rhesus monkeys.
    Fredericks AB; Benowitz NL; Savanapridi CY
    J Pharmacol Exp Ther; 1981 Feb; 216(2):247-53. PubMed ID: 6257883
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Heart rate behavior and the ischemic ST-segment under carteolol hydrochloride. Dose-response relationship and duration of effect].
    Kober G; Veidt J; Mikludy R; Kaltenbach M
    Arzneimittelforschung; 1983; 33(2a):313-7. PubMed ID: 6682323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat.
    Nekooeian AA; Tabrizchi R
    Br J Pharmacol; 1998 Apr; 123(8):1666-72. PubMed ID: 9605574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antihypertensive properties of tiapamil (RO 11-1781)--a new calcium antagonist--in patients with mild and moderate essential hypertension.
    Velasco M; Morillo J; Urbina A; Kögler P; Leishman B; Pasquier M; Hernändez-Pieretti O
    Int J Clin Pharmacol Res; 1987; 7(6):443-54. PubMed ID: 3440635
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of ionophore monensin on anaesthetized dogs in hemorrhagic hypotension.
    Gupta RK; Babbar R; Fahim M
    Vascul Pharmacol; 2005 Jan; 42(2):69-75. PubMed ID: 15722252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
    Daul A; Hermes U; Schäfers RF; Wenzel R; von Birgelen C; Brodde OE
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The complex formation of etilefrin with high molecular weight aqueons solutions of adjuvants].
    Mehlhorn R; Horsch W
    Pharmazie; 1975 Nov; 30(11):749-50. PubMed ID: 3805
    [No Abstract]   [Full Text] [Related]  

  • 48. The cardiovascular effects of etilefrine.
    Coleman AJ; Leary WP; Asmal AC
    Eur J Clin Pharmacol; 1975; 8(1):41-5. PubMed ID: 9293
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Formation of a direct mutagen, diazo-N-nitrosoetilefrin, by interaction of etilefrin with nitrite.
    Kikugawa K; Kato T; Takeda Y
    Chem Pharm Bull (Tokyo); 1989 Jun; 37(6):1600-3. PubMed ID: 2570647
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Norfenefrine in the treatment of female urinary stress incontinence assessed by one-hour pad weighing test.
    Diernaes E; Rix P; Sørensen T; Alexander N
    Urol Int; 1989; 44(1):28-31. PubMed ID: 2568712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thermogenic agents in the treatment of human obesity: preliminary results.
    Pasquali R; Cesari MP; Besteghi L; Melchionda N; Balestra V
    Int J Obes; 1987; 11 Suppl 3():23-6. PubMed ID: 2894367
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effortil in treatment of cardiovascular surgical complications].
    FRANK-SCHMIDT HJ
    Dtsch Med J; 1955 Aug; 6(15-16):540-3. PubMed ID: 13261800
    [No Abstract]   [Full Text] [Related]  

  • 53. Drugs for hypotension: disproportionate harms with etilefrine and heptaminol.
    Prescrire Int; 2015 Jul; 24(162):184. PubMed ID: 26240886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New developments in pharmacological treatments for obesity.
    Sullivan AC; Hogan S; Triscari J
    Ann N Y Acad Sci; 1987; 499():269-76. PubMed ID: 3300486
    [No Abstract]   [Full Text] [Related]  

  • 55. [Experience with effortil in pediatrics].
    ALLIES F
    Kinderarztl Prax; 1956 Mar; 24(3):102-10. PubMed ID: 13320708
    [No Abstract]   [Full Text] [Related]  

  • 56. [Phetanol].
    Farmatsiia; 1977; 26(3):88-9. PubMed ID: 19304
    [No Abstract]   [Full Text] [Related]  

  • 57. Determination of microquantity of ethylphenylephrine in plasma by radioisotope derivative method using p-toluenesulfonyl[35S] chloride.
    Hiraoka T
    Chem Pharm Bull (Tokyo); 1974 Nov; 22(11):2511-7. PubMed ID: 4157067
    [No Abstract]   [Full Text] [Related]  

  • 58. [Contribution on treatment of infantile hypotensive circulatory regulation disorders].
    KIRCHHOFF HW
    Ther Ggw; 1955 Aug; 94(8):289-92. PubMed ID: 13291254
    [No Abstract]   [Full Text] [Related]  

  • 59. [The hypertensive effect of adyston and etilefrin. Comparative animal experimental studies].
    Statkov PR
    Fortschr Med; 1978 May; 96(19):1046-8. PubMed ID: 25832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evaluation of the effectiveness of Thomasin (etilefrin) in hypotensive and/or orthostatic circulatory disorders in comparison with pholedrine and placebo (double-blind study)].
    Gruber G
    Z Arztl Fortbild (Jena); 1982 Feb; 76(4):149-53. PubMed ID: 6125062
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.